Publications
Original Article
Dendritic cells lose ability to present protein antigen after stimulating antigen-specific T cell responses, despite upregulation of MHC class II expression
Tumor Microenvironment
2000
Authors:
Bernhard H, Huseby ES, Hand SL, Lohmann M, Batten WY, Disis ML, Gralow JR, Meyer zum Bruschenfelde KH, Ohlen C and Cheever MA
Journal:
Immunobiology
Volume:
201(5)
Page:
568-82
Original Article
Pre-existent immunity to the HER-2/neu oncogenic protein in patients with HER-2/neu overexpressing breast and ovarian cancer
Cancer Vaccines
2000
Authors:
Disis ML, Knutson KL, Schiffman K, Rinn K, McNeel DG
Journal:
Breast Cancer Research and Treatment
Volume:
62(3)
Page:
245-52
Original Article
Delayed-type hypersensitivity response is a predictor of peripheral blood T-cell immunity after HER-2/neu peptide immunization
Cancer Vaccines
2000
Authors:
Disis ML, Schiffman K, Gooley TA, McNeel DG, Rinn K and Knutson KL
Journal:
Clinical Cancer Research
Volume:
6(4)
Page:
1347-50
Original Article
Immunity to WT1 in the animal model and in patients with acute myeloid leukemia
Cancer Vaccines
2000
Authors:
Gaiger A, Reese V, Disis ML and Cheever MA
Journal:
Blood
Volume:
96(4)
Page:
1480-9
Review Article
Cancer vaccines for the treatment and prevention of non small-cell lung cancer
Cancer Vaccines
2000
Authors:
Disis ML, West HL, and Schiffman K
Journal:
Clincal Lung Cancer
Volume:
1(4)
Page:
294-301
Review Article
Tumor vaccines for the management of prostate cancer
Cancer Vaccines
2000
Authors:
McNeel DG and Disis ML
Journal:
Arch Immunol Ther Exp
Volume:
48(2)
Page:
85-93
Review Article
Immunotherapeutic approaches for the treatment of breast cancer
Cancer Vaccines
1999
Authors:
Knutson KL, Schiffman K, Rinn K, and Disis ML
Journal:
Journal of Mammary Gland Biology and Neoplasia
Volume:
4(4)
Page:
353-65
Review Article
Peptide Based Tumor Vaccines
Cancer Vaccines
1999
Authors:
Disis ML, McNeel DG, Schiffman KA, Rinn K, and Knutson KL
Journal:
Endocrine & Metabolic Investigational Drugs
Volume:
1(3)
Page:
253-9
Original Article
Immunization with recombinant human granulocyte-macrophage colony-stimulating factor as a vaccine adjuvant elicits both a cellular and humoral response to recombinant human granulocyte-macrophage colony-stimulating factor
Clinical Trials
1999
Authors:
McNeel DG, Schiffman K, Disis ML
Journal:
Blood
Volume:
93(8)
Page:
2653-9
Original Article
Generation of immunity to the HER-2/neu oncogenic protein in patients with breast and ovarian cancer using a peptide-based vaccine
Cancer Vaccines
1999
Authors:
Disis ML, Grabstein KH, Sleath PR and Cheever MA
Journal:
Clinical Cancer Research
Volume:
5(6)
Page:
1289-97